The Number 1 Small-Cap Biotech Investors are Missing Out On Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a small-cap biotech company that investors should consider. Source: BioSpace You Might Also Like FDA Approval of Drug May Have Made This Bay Area Pharma a New M&A Target June 26, 2017 Besties Regeneron, Sanofi Show Off Phase II Skin Cancer Data December 12, 2017 ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2 September 10, 2017
ImmusanT, Inc. Presents Data From Multiple Studies Supporting Continued Development Of Nexvax2 September 10, 2017
